These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25781442)

  • 21. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
    Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
    Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
    Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
    Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk.
    Khankari NK; Banbury BL; Borges MC; Haycock P; Albanes D; Arndt V; Berndt SI; Bézieau S; Brenner H; Campbell PT; Casey G; Chan AT; Chang-Claude J; Conti DV; Cotterchio M; English DR; Figueiredo JC; Giles GG; Giovannucci EL; Gunter MJ; Hampe J; Hoffmeister M; Hopper JL; Jenkins MA; Joshi AD; Marchand LL; Lemire M; Li CI; Li L; Lindblom A; Martín V; Moreno V; Newcomb PA; Offit K; Pharoah PDP; Rennert G; Sakoda LC; Schafmayer C; Schmit SL; Slattery ML; Song M; Thibodeau SN; Ulrich CM; Weinstein SJ; White E; Win AK; Wolk A; Woods MO; Wu AH; Cai Q; Denny JC; Edwards TL; Murff HJ; Gruber SB; Peters U; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):860-870. PubMed ID: 32051193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
    Davies JR; Mell T; Fuller H; Harland M; Saleh RNM; Race AD; Rees CJ; Brown LC; Loadman PM; Downing A; Minihane AM; Williams EA; Hull MA
    Cancer Prev Res (Phila); 2023 Nov; 16(11):621-629. PubMed ID: 37756582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.
    Resler AJ; Makar KW; Heath L; Whitton J; Potter JD; Poole EM; Habermann N; Scherer D; Duggan D; Wang H; Lindor NM; Passarelli MN; Baron JA; Newcomb PA; Le Marchand L; Ulrich CM
    Carcinogenesis; 2014 Sep; 35(9):2121-6. PubMed ID: 24908683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.
    Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
    Pharmacogenet Genomics; 2009 Feb; 19(2):113-20. PubMed ID: 19077918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.
    Chan AT; Ogino S; Giovannucci EL; Fuchs CS
    Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
    Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
    Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
    Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E; Rothwell PM;
    Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.
    Brasky TM; Bonner MR; Moysich KB; Ochs-Balcom HM; Marian C; Ambrosone CB; Nie J; Tao MH; Edge SB; Trevisan M; Shields PG; Freudenheim JL
    Breast Cancer Res Treat; 2011 Feb; 126(1):157-65. PubMed ID: 20676755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use.
    Siersema PD; Yu S; Sahbaie P; Steyerberg EW; Simpson PW; Kuipers EJ; Triadafilopoulos G
    Gastrointest Endosc; 2006 Apr; 63(4):581-6. PubMed ID: 16564855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.
    Wilson JC; O'Rorke MA; Cooper JA; Murray LJ; Hughes CM; Gormley GJ; Anderson LA
    Cancer Epidemiol; 2013 Dec; 37(6):897-904. PubMed ID: 24042024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
    Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
    Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
    Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
    Mahipal A; Anderson KE; Limburg PJ; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
    Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2020 May; 51(9):899-908. PubMed ID: 32201976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.